Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway

Fig. 1

Significantly decreased ARHGAP30 expression in tumor tissues from patients with pancreatic cancer and pancreatic cancer cell lines. a Thirty paired cancer and adjacent tissues were collected from patients, and ARHGAP30 mRNA expression was detected using RT-PCR. b Statistical analysis of ARHGAP30 protein expression in 90 paraffin-embedded pancreatic cancer and adjacent tissues. c Immunohistochemical detection of ARHGAP30 expression and Kaplan–Meier survival analysis and log-rank comparison of 90 patients with pancreatic cancer, including 59 cases of death (high ARHGAP30 expression: 20, low ARHGAP30 expression: 39). d ARHGAP30 mRNA and protein expression in pancreatic cancer cell lines (ASPC1, BXPC3, MiaPaca2, PANC1 and SW1990) and normal human pancreas cells (HPC-Y5) was detected using RT-PCR and western blotting, respectively. *p < 0.05, **p < 0.01, ***p < 0.001 vs. HPC-Y5

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us